Literature DB >> 34090780

Reproductive-Age Women's Experience of Accessing Treatment for Opioid Use Disorder: "We Don't Do That Here".

Julia C Phillippi1, Rebecca Schulte2, Kemberlee Bonnet2, David D Schlundt2, William O Cooper3, Peter R Martin4, Katy B Kozhimannil5, Stephen W Patrick3.   

Abstract

PURPOSE: For reproductive-age women, medications for opioid use disorder (OUD) decrease risk of overdose death and improve outcomes but are underutilized. Our objective was to provide a qualitative description of reproductive-age women's experiences of seeking an appointment for medications for OUD.
METHODS: Trained female callers placed telephone calls to a representative sample of publicly listed opioid treatment clinics and buprenorphine providers in Florida, Kentucky, Massachusetts, Michigan, Missouri, North Carolina, Tennessee, Virginia, Washington, and West Virginia to obtain appointments to receive medication for OUD. Callers were randomly assigned to be pregnant or non-pregnant and have private or Medicaid-based insurance to assess differences in the experiences of access by these characteristics. The callers placed 28,651 uniquely randomized calls, 10,117 to buprenorphine-waivered prescribers and 754 to opioid treatment programs. Open-ended, qualitative data were obtained from the callers about the access experiences and were analyzed using a qualitative, iterative inductive-deductive approach. From all 28,651 total calls, there were 17,970 unique free-text comments to the question "Please give an objective play-by-play of the description of what happened in this conversation."
FINDINGS: Analysis demonstrated a common path to obtaining an appointment. Callers frequently experienced long hold times, multiple transfers, and difficult interactions. Clinic receptionists were often mentioned as facilitating or obstructing access. Pregnant callers and those with Medicaid noted more barriers. Obtaining an appointment was commonly difficult even for these persistent, trained callers.
CONCLUSIONS: Interventions are needed to improve the experiences of reproductive-age women as they enter care for OUD, especially for pregnant women and those with Medicaid coverage.
Copyright © 2021 Jacobs Institute of Women's Health. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34090780      PMCID: PMC9111968          DOI: 10.1016/j.whi.2021.03.010

Source DB:  PubMed          Journal:  Womens Health Issues        ISSN: 1049-3867


  30 in total

Review 1.  Access in health services research: the battle of the frameworks.

Authors:  Thomas C Ricketts; Laurie J Goldsmith
Journal:  Nurs Outlook       Date:  2005 Nov-Dec       Impact factor: 3.250

2.  State Policies That Treat Prenatal Substance Use As Child Abuse Or Neglect Fail To Achieve Their Intended Goals.

Authors:  Danielle N Atkins; Christine Piette Durrance
Journal:  Health Aff (Millwood)       Date:  2020-05       Impact factor: 6.301

3.  Auditing access to specialty care for children with public insurance.

Authors:  Joanna Bisgaier; Karin V Rhodes
Journal:  N Engl J Med       Date:  2011-06-16       Impact factor: 91.245

4.  Facilitators of prenatal care access in rural Appalachia.

Authors:  Julia C Phillippi; Carole R Myers; Mavis N Schorn
Journal:  Women Birth       Date:  2014-08-30       Impact factor: 3.172

5.  Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2017-08       Impact factor: 7.661

6.  Primary care appointment availability for new Medicaid patients increased after Medicaid expansion in Michigan.

Authors:  Renuka Tipirneni; Karin V Rhodes; Rodney A Hayward; Richard L Lichtenstein; Elyse N Reamer; Matthew M Davis
Journal:  Health Aff (Millwood)       Date:  2015-08       Impact factor: 6.301

7.  The Motivation-Facilitation Theory of Prenatal Care Access.

Authors:  Julia C Phillippi; Marian W Roman
Journal:  J Midwifery Womens Health       Date:  2013-08-16       Impact factor: 2.388

Review 8.  Women's perceptions of access to prenatal care in the United States: a literature review.

Authors:  Julia C Phillippi
Journal:  J Midwifery Womens Health       Date:  2009 May-Jun       Impact factor: 2.388

9.  Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder.

Authors:  Stephen W Patrick; Michael R Richards; William D Dupont; Elizabeth McNeer; Melinda B Buntin; Peter R Martin; Matthew M Davis; Corey S Davis; Katherine E Hartmann; Ashley A Leech; Kim S Lovell; Bradley D Stein; William O Cooper
Journal:  JAMA Netw Open       Date:  2020-08-03

10.  In their own words: a qualitative study of factors promoting resilience and recovery among postpartum women with opioid use disorders.

Authors:  Daisy J Goodman; Elizabeth C Saunders; Kristina B Wolff
Journal:  BMC Pregnancy Childbirth       Date:  2020-03-18       Impact factor: 3.007

View more
  1 in total

1.  "You have to take this medication, but then you get punished for taking it:" lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period.

Authors:  Davida M Schiff; Erin C Work; Serra Muftu; Shayla Partridge; Kathryn Dee L MacMillan; Jessica R Gray; Bettina B Hoeppner; John F Kelly; Shelly F Greenfield; Hendrée E Jones; Timothy E Wilens; Mishka Terplan; Judith Bernstein
Journal:  J Subst Abuse Treat       Date:  2022-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.